Vertex Pharmaceuticals will spend $10 billion to acquire Crinetics Pharmaceuticals and its drug for a rare endocrine disorder ...

Palmer is investigating how telehealth is driving the consumerization of drugs. This is Part 6 of the series The VirtualRx Boom. Katie covers the impact of health technology on patients, clinicians, ...

Rose covers disability and mental health, and she helps write STAT’s daily Morning Rounds newsletter. Confidential tips can be sent to Rose on Signal at rosebroderick.11. Annalisa (Nalis) Merelli is ...

Call AI in biotech hype at your peril. There are real reasons that pharmaceutical companies are embracing this technology ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — Clinical trial policy ...

Reducing Medicare payments for 340B drugs is the latest proposal focused on the hotly debated drug discount program.

Dozens of congressional lawmakers are urging the Trump administration to force Eli Lilly to reinstate mandated price breaks ...

Elevance Health has sued the U.S. government, alleging that federal efforts to recalculate its Medicare Advantage quality ...

Colorado Democratic Rep. Diana DeGette, who lost her primary, was knowledgeable about biopharma, if not always a friend to ...

Biotech's bull market, Vertex's gene therapy expansion, and more news from The Readout ...

A U.S. Centers for Medicare & Medicaid Services 18-month ​trial program will offer for the first time Novo Nordisk’s Wegovy ...

A federal judge blocked a Colorado state panel from placing a cap on the price of Enbrel, a blockbuster drug sold by Amgen ...